• 0
Shop Products $

Prostaglandin E1. (PGE1). Light-yellow solid. Activates adenylate cyclase activity via a G-protein coupled receptor. Purity: = 98% by TLC. Soluble in DMSO and EtOH. RTECS GY4569800, CAS 745-65-3, M.W. 354.5. WARNING! Toxic. LD50 of 500 mg/kg. May be carcinogenic/teratogenic.

Prostaglandin E2. (PGE2). Light-yellow solid. Involved in vasodilator actions of kinins such as bradykinin. Inhibits MAP kinase in rat mesangial cells (IC50 = 25 - 50 mM). Regulates the activity of adenylate cyclase via G-protein coupled receptors. Purity: 98% by TLC. Soluble in EtOH.

Prostaglandin F2a. (PGF2a). White solid. PROTECT FROM MOISTURE. Major uterine luteolytic prostaglandin. A pulmonary vasoconstrictor. Purity: = 98% by TLC. Soluble in EtOH. RTECS UK8020000, CAS 551-11-1, M.W. 354.5. WARNING! May be carcinogenic/teratogenic.

Prostaglandin D2. (PGD2). Crystalline solid. Major prostaglandin metabolite in brain and an important inflammatory mediator in mast cells. Neuromodulator that evokes nerve-mediated Cl- secretion. Stimulates adenylate cyclase. Purity: 98% by TLC. Soluble in acetone, EtOH, EtOAc and MeOH.

Prothrombin, Human Plasma. (Coagulation Factor II). Solid lyophilized from 100 mM NaCl, 20 mM Tris-HCl, 1 mM benzamidine, pH 7.5. Vitamin K-dependent glycoprotein synthesized in the liver. Conversion to thrombin is a key step in the blood coagulation pathway and catalyzes coagulation of fibrinogen.

Prothrombin, Human Plasma. (Coagulation Factor II). Solid lyophilized from 100 mM NaCl, 20 mM Tris-HCl, 1 mM benzamidine, pH 7.5. Vitamin K-dependent glycoprotein synthesized in the liver. Conversion to thrombin is a key step in the blood coagulation pathway and catalyzes coagulation of fibrinogen.

Protein Kinase Ce Peptide Substrate. (Peptide-e; H-Glu-Arg-Met-Arg-Pro-Arg-Lys-Arg-Gln-Gly-Ser-Val-Arg-Arg-Arg-Val-OH). White solid. HYGROSCOPIC. Pseudosubstrate region of the e-isotype of protein kinase C (PKCe), with an alanine to serine substitution.

SIALYL LEWIS X 1MG - 565950-1MG

Sialyl Lewis x. ( [SLex; Neu5Aca2,3Galb1,4(Fuc1,2)GlcNAc]). White solid. Enzymatically prepared tetrasaccharide which acts as a minimal binding ligand for E-selectins. SLex reduces injury following ischemia and reperfusion and immune complex-induced acute lung injury in animal models.

D-erythro-Sphingosine, Free Base, Bovine Brain, High Purity. (Cerebroside; trans-D-erythro-2-amino-4-octadecene-1,3-diol). White solid. Highly purified preparation of Cat. No. 567725 containing 99% of the erythro isomer. Purity: 99% by TLC. Soluble in DMSO, EtOH and MeOH. CAS 123-78-4, M.W. 299.

1-Stearoyl-2-arachidonoyl-sn-glycerol. Clear oil. PACKAGED UNDER INERT GAS. Diacylglycerol derivative. Endogenous activator of protein kinase C. Produced via receptor-mediated inositol phospholipid hydrolysis. Purity: = 95% by TLC. Soluble in DMSO and EtOH. CAS 65914-84-3, M.W. 645.0.

THROMBIN PLASMINOGEN- 1KU - 605160-1KU

Thrombin, Human Plasma. Lyophilized from 200 mM NaCl, 50 mM citrate buffer, 0.1% PEG-8000, pH 6.5. Specific activity: 1000 NIH units/mg protein. One unit is determined by comparison with a standard curve prepared by using the Bureau of Biologics standard thrombin.

Thrombin, Human Plasma. Lyophilized from 200 mM NaCl, 50 mM citrate buffer, 0.1% PEG-8000, pH 6.5. Specific activity: 1000 NIH units/mg protein. One unit is determined by comparison with a standard curve prepared by using the Bureau of Biologics standard thrombin.

Thrombin, Human Plasma, High Activity. Lyophilized from 200 mM NaCl, 50 mM sodium citrate, 0.1% PEG, pH 6.5. Designed for use in thrombin time tests. Specific activity: 2800 NIH units/mg protein.

Thrombin, Human Plasma, High Activity. Lyophilized from 200 mM NaCl, 50 mM sodium citrate, 0.1% PEG, pH 6.5. Designed for use in thrombin time tests. Specific activity: 2800 NIH units/mg protein.

Thrombin, Human Plasma, High Activity. Lyophilized from 200 mM NaCl, 50 mM sodium citrate, 0.1% PEG, pH 6.5. Designed for use in thrombin time tests. Specific activity: 2800 NIH units/mg protein.

Thrombin, Citrate-Free, Human Plasma. Liquid. In 100 mM NaCl, 20 mM Tris-HCl, pH 7.4. Formulation useful for procedures in which presence of citrate is undesirable. Specific activity: 2500 NIH units/mg protein.

von Willebrand Factor, Human Plasma. (vWF). Lyophilized solid containing citrate, glycine, and NaCl. Glycoprotein complex found in plasma, platelets, and subendothelium. Purity: = 95% by SDS-PAGE. Soluble in H2O.

Caspase-1 Substrate VI, Fluorogenic. (Z-YVAD-AFC; Z-Tyr-Val-Ala-Asp-AFC). Fluorogenic caspase-1 substrate. Purity: single spot by TLC. Soluble in DMSO. White to off-white solid, 5mg.

Follicle Stimulating Hormone, Human Pituitary, Iodination Grade. (hFSH). Lyophilized solid. Two-chain glycoprotein gonadotropic hormone that induces maturation of the Graafian follicles of the ovary. Promotes the development of germinal cells in males.

Follicle Stimulating Hormone, Human Pituitary, Iodination Grade. (hFSH). Lyophilized solid. Two-chain glycoprotein gonadotropic hormone that induces maturation of the Graafian follicles of the ovary. Promotes the development of germinal cells in males.

Luteinizing Hormone, Human Pituitary, Iodination Grade. (hLH). Lyophilized solid. Two-chain glycoprotein hormone required for ovulation, spermatogenesis and the biosynthesis of sex steroids. Biological specificity has been attributed to b-chain. Potency: 5000 IU/mg (WHO IRP 68/40).

Luteinizing Hormone, Human Pituitary, Iodination Grade. (hLH). Lyophilized solid. Two-chain glycoprotein hormone required for ovulation, spermatogenesis and the biosynthesis of sex steroids. Biological specificity has been attributed to b-chain. Potency: 5000 IU/mg (WHO IRP 68/40).

Thyroid Stimulating Hormone, Human Pituitary, Iodination Grade. (hTSH). Lyophilized solid. Immunopotency: 6 IU/mg (WHO 1st IRP 68/38). Contaminants: hLH: 0.3% by weight; hGH and hFSH: each 0.2% by weight; hPRL: 0.1% by weight. Solubilize in iodination buffer.

Thyroid Stimulating Hormone, Human Pituitary, Iodination Grade. (hTSH). Lyophilized solid. Immunopotency: 6 IU/mg (WHO 1st IRP 68/38). Contaminants: hLH: 0.3% by weight; hGH and hFSH: each 0.2% by weight; hPRL: 0.1% by weight. Solubilize in iodination buffer.

Thyroid Stimulating Hormone, Human Pituitary, Iodination Grade. (hTSH). Lyophilized solid. Immunopotency: 6 IU/mg (WHO 1st IRP 68/38). Contaminants: hLH: 0.3% by weight; hGH and hFSH: each 0.2% by weight; hPRL: 0.1% by weight. Solubilize in iodination buffer.

Growth Hormone, Human Pituitary, Iodination Grade. (hGH; somatotropin). Lyophilized solid. Single chain polypeptide hormone essential for growth of all tissues. Increases fat mobilization. Immunopotency: = 5 IU/mg (WHO 1st IRP). Contaminants: hFSH, hPRL, hLH, and hTSH: = 0.05%.

Growth Hormone, Human Pituitary, Iodination Grade. (hGH; somatotropin). Lyophilized solid. Single chain polypeptide hormone essential for growth of all tissues. Increases fat mobilization. Immunopotency: = 5 IU/mg (WHO 1st IRP). Contaminants: hFSH, hPRL, hLH, and hTSH: = 0.05%.

Chorionic Gonadotropin, Human Urine, Iodination Grade. Lyophilized solid. Immunopotency: 16,000 IU/mg (WHO 1st IRP 75/551). Purity: 95% by SDS-PAGE. Soluble in H2O. Prepared from urine that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.

Prolactin, Human Pituitary, Iodination Grade. (hPRL). Lyophilized solid. Single chain peptide hormone required for lactation in mammals. Inhibits the secretion of gonadotropins. Prolactin receptors are present in breast tissue, adrenals, ovary, testis, kidney and liver.

Amiloride, HCl. Light yellow solid. PROTECT FROM LIGHT. An inhibitor of angiogenesis. Inhibits capillary morphogenesis completely and reversibly at approximately 130 mM. At low concentrations, acts as a potent and specific inhibitor of transmembrane Na+ entry and Na+-K+-ATPase.

Nifedipine. Yellow solid. PROTECT FROM LIGHT. Relatively selective blocker of L-type Ca2+ channels. One of the most extensively studied Ca2+ channel blockers of 1,4-dihydropyridine-type and a pharmacologically useful vasodilator. Induces apoptosis in human glioblastoma cells.

(+/-)-Verapamil, HCl. A derivative of papaverine that blocks Ca2+ channels (principally the L-type) in smooth and cardiac muscle cells. Vasodilator and antiarrhythmic agent. Purity: 99% by TLC. Soluble in ethanol, methanol, and water. CAS: 23313-68-0. FW: 491.1. White solid, 100mg.

A23187, Free Acid, Streptomyces chartreusensis. (Calcimycin) Mobile ion-carrier that forms stable complexes with divalent cations. Purity: =98% by TLC. Soluble in DMSO and methanol. CAS: 52665-69-7. FW: 523.6. White solid, 10mg.

A23187, Free Acid, Streptomyces chartreusensis. (Calcimycin) Mobile ion-carrier that forms stable complexes with divalent cations. Purity: =98% by TLC. Soluble in DMSO and methanol. CAS: 52665-69-7. FW: 523.6. White solid, 1mg.

A23187, Free Acid, Streptomyces chartreusensis. (Calcimycin) Mobile ion-carrier that forms stable complexes with divalent cations. Purity: =98% by TLC. Soluble in DMSO and methanol. CAS: 52665-69-7. FW: 523.6. White solid, 50mg.

A23187, Free Acid, Streptomyces chartreusensis. (Calcimycin) Mobile ion-carrier that forms stable complexes with divalent cations. Purity: =98% by TLC. Soluble in DMSO and methanol. CAS: 52665-69-7. FW: 523.6. White solid, 5mg.

A23187, Mixed Calcium-Magnesium Salt. Useful in cell activation experiments when calcium dose-response data are not required. Purity: =98% by TLC. Soluble in DMSO and ethanol. Yellow crystalline solid, 10mg.

A23187, 4-Bromo-. Yellow solid. PROTECT FROM LIGHT. HYGROSCOPIC. Brominated analog of the widely used cation ionophore A23187 (Cat. No. 100105). Non-fluorescent and therefore suitable for use in the presence of fluorescent or metal-chelating probes. Purity: = 85% by HPLC. Soluble in DMSO.

Acetylcoenzyme A, Trilithium. White solid. HYGROSCOPIC. Carrier of acyl groups in enzymatic reactions in fatty acid synthesis and oxidation and in biological acetylations. Soluble in H2O. CAS 75520-41-1, M.W. 827.1. WARNING! Harmful. LD50 of 2000 mg/kg.

Acetylcoenzyme A, Trilithium. White solid. HYGROSCOPIC. Carrier of acyl groups in enzymatic reactions in fatty acid synthesis and oxidation and in biological acetylations. Soluble in H2O. CAS 75520-41-1, M.W. 827.1. WARNING! Harmful. LD50 of 2000 mg/kg.

N-Acetylneuraminic Acid, Synthetic. (NANA; lactaminic acid; sialic acid). Off-white solid. PROTECT FROM LIGHT. HYGROSCOPIC. Purity: = 98% by HPLC. Soluble in H2O. CAS 131-48-6, M.W. 309.3.

(+/-)-Bay K 8644. ( {1,4-Dihydro-2,6-dimethyl-5-nitro-4-[2'' -(trifluoromethyl)phenyl]-3-pyridinecarboxylic acid methyl ester}). Yellow solid. Synthetic dihydropyridine derivative that acts as an active Ca2+ slow channel agonist in neuroendocrine, muscle, thyroid and other cell types.

(+/-)-Bay K 8644. ( {1,4-Dihydro-2,6-dimethyl-5-nitro-4-[2'' -(trifluoromethyl)phenyl]-3-pyridinecarboxylic acid methyl ester}). Yellow solid. Synthetic dihydropyridine derivative that acts as an active Ca2+ slow channel agonist in neuroendocrine, muscle, thyroid and other cell types.

2-Deoxy-D-glucose. White solid. Non-metabolizable derivative of glucose that can be carried by the glucose carrier in human erythrocytes. An indirect inhibitor of hexokinase. Reported to reduce the incidence of doxorubicin-induced apoptosis. Purity: = 98% by GC. Soluble in H2O.

Dexamethasone. Most active and highly stable glucocorticoid. Inhibits the expression of inducible but not constitutive nitric oxide synthase in vascular endothelial cells (IC5=5nM). CAS: 50-02-2. FW: 392.5. Purity: =99% by TLC. Soluble in DMSO, ethanol. White solid, 100mg.

17[beta]-Estradiol. Most potent mammalian estrogenic hormone. Induces nitric oxide synthase in the aorta. Purity: =97% by HPLC. Soluble in ethanol. CAS: 50-28-2. FW: 272.4. White to off-white solid, 1g.

D-Fructose-6-phosphate, Disodium. White solid. HYGROSCOPIC. A glycolytic intermediate formed by the isomerization of glucose-6-phosphate. Soluble in H2O. CAS 26177-86-6, M.W. 304.1.

a-D-Glucose-6-phosphate, Monosodium. Crystalline solid. Non-hygroscopic and more stable than the disodium salt. Purity: 99% by enzymatic assay. Soluble in aqueous buffers and H2O. CAS 54010-71-8, M.W. 282.1.

a-D-Glucose-6-phosphate, Monosodium. Crystalline solid. Non-hygroscopic and more stable than the disodium salt. Purity: 99% by enzymatic assay. Soluble in aqueous buffers and H2O. CAS 54010-71-8, M.W. 282.1.

Hyaluronic Acid, Streptococcus sp., Sodium. Lyophilized solid. PROTECT FROM MOISTURE. Natural high-viscosity mucopolysaccharide with alternating b1,3-glucuronidic and b1,4-glucosaminidic bonds. Principal glycosaminoglycan in connective tissue fluids. Contaminants: protein: = 0.1%. Soluble in H2O.

Ionomycin, Free Acid, Streptomyces conglobatus. Pale-yellow oil. PROTECT FROM LIGHT. PACKAGED UNDER INERT GAS. Highly specific for divalent cations and more effective than antibiotic A23187 (Cat. No. 100105) as a mobile ion carrier for Ca2+. Complexes with Ca2+ between pH 7 and 9.5.

Ionomycin, Free Acid, Streptomyces conglobatus. Pale-yellow oil. PROTECT FROM LIGHT. PACKAGED UNDER INERT GAS. Highly specific for divalent cations and more effective than antibiotic A23187 (Cat. No. 100105) as a mobile ion carrier for Ca2+. Complexes with Ca2+ between pH 7 and 9.5.

Ionomycin, Free Acid, Streptomyces conglobatus. Pale-yellow oil. PROTECT FROM LIGHT. PACKAGED UNDER INERT GAS. Highly specific for divalent cations and more effective than antibiotic A23187 (Cat. No. 100105) as a mobile ion carrier for Ca2+. Complexes with Ca2+ between pH 7 and 9.5.

Melatonin. A hormone that has been postulated as the mediator of photic-induced anti-gonadotropic activity in photoperiodic mammals. CAS: 73-31-4. FW: 232.3. Purity: =98% by HPLC. Soluble in ethanol. 1g off-white solid.

Normal Guinea Pig Serum, Lyophilized.

Thrombin, Immobilized, Human Plasma. One vial contains 1 ml cross-linked beaded 6% agarose gel without a spacer in 50 mM K2HPO4, 0.02% NaN3, pH 7.5. Contains 250 mg Thrombin (Cat. No. 605190) per ml gel. DO NOT FREEZE.

UDP-a-D-Glucose, Disodium. (UDPG; uridine-5'' -diphosphoglucose, sodium). Off-white solid. Purity: = 98% HPLC. Soluble in H2O. CAS 117756-22-6, M.W. 610.3.

Corticosterone. ( [(11b)-11,21-Dihydroxypregn-4-ene-3,20-dione; Reichstein'' s substance H]). White crystalline powder. Corticosteroid hormone synthesized in response to stress.

Diltiazem, HCl. White solid. Synthetic benzothiazepine that acts as an L-type Ca2+ channel antagonist. Similar in function to Nifedipine (Cat. No. 481981) and Verapamil (Cat. No. 676777). Has negative inotropic effects on the heart.

D-(+)-Galactosamine, HCl. Colorless solid. A powerful inhibitor of hepatic RNA synthesis. Increases the adherence of polymorphonuclear leukocytes to hepatic endothelial cells and induces superoxide production. Induces hepatic damage, causing macrophage infiltration. Soluble in H2O.

D-Galactose. White solid. Purity: = 98% by HPLC. Soluble in H2O. RTECS LW5490000, CAS 59-23-4, M.W. 180.2.

Heparin, Porcine Intestinal Mucosa, Sodium. (HEP, sodium). Lyophilized solid. Preservative-free, non-sterile. Highly sulfated dextrorotatory mucopolysaccharide with specific anticoagulant properties. Inhibits the IP3-activated Ca2+ release channel of the endoplasmic reticulum.

Hydrocortisone, Chromatographic Standard. White solid. Conforms to USP Reference Standard. Purity: 99% by TLC. Soluble in EtOH. RTECS GM8925000, CAS 50-23-7, M.W. 362.5. WARNING! May be carcinogenic/teratogenic.

Hydrocortisone. (Cortisol). Off-white solid. Steroid hormone of the adrenal cortex. Has anti-inflammatory properties. Purity: = 97% by HPLC. Soluble in EtOH. RTECS GM8925000, CAS 50-23-7, M.W. 362.5. WARNING! May be carcinogenic/teratogenic.

D-Mannose. (D-Mannopyranose). White solid. Purity: = 98% by GC and HPLC. Heavy metals: 10 ppm. Soluble in H2O. CAS 3458-28-4, M.W. 180.2.

2-Methoxyestradiol. ( [2-Methoxy-3,17b-dihydroxyestra-1,3,5(10)-triene]). White crystalline solid. A natural metabolite of 17b-estradiol which is devoid of estrogenic activity. Inhibits cell proliferation and angiogenesis.

2-Methoxyestradiol. ( [2-Methoxy-3,17b-dihydroxyestra-1,3,5(10)-triene]). White crystalline solid. A natural metabolite of 17b-estradiol which is devoid of estrogenic activity. Inhibits cell proliferation and angiogenesis.

Methyl-a-D-mannopyranoside. (a-Methyl-D-mannoside). White solid. Substrate for a1,2-Mannosyltransferase (Cat. No. 462711). Lectin inhibitory sugar. Purity: = 98% by GC. Contaminants: glucose: 0.1%. Heavy metals: 5 ppm. Soluble in H2O. CAS 617-04-9, M.W. 194.2.

Progesterone. (D4-Pregnene-3,20-dione). White solid. Steroid hormone secreted by the corpus luteum during the latter half of the menstrual cycle. Binds to the progesterone receptor in the nucleus to influence transcription. Used as a contraceptive agent and in the treatment of uterine disorders.

QX-314. White crystalline solid. PROTECT FROM LIGHT. A quaternary lidocaine derivative, permanently charged and lipophobic. A powerful blocker of voltage-sensitive Na+ conductance when applied intracellularly.

D-GLUCONIC ACID POTASSIUM 100G - 346125-100GM

NADP, Disodium Salt. 100mg. Beta-Nicotinamide-adenine Dinucleotide Phosphate. TPN, 2Na. Off-white solid. A coenzyme that is widely distributed in living matter. Participates in oxidation-reduction reactions. Purity: 95% by enzymatic assay. CAS 24292-60-2.

NADP, Disodium Salt. 1gm. Beta-Nicotinamide-adenine Dinucleotide Phosphate. TPN, 2Na. Off-white solid. A coenzyme that is widely distributed in living matter. Participates in oxidation-reduction reactions. Purity: 95% by enzymatic assay. CAS 24292-60-2.

BETA-SITOSTEROL (1.03739)-25GM - 567152-25GM, 25 g

BETA-SITOSTEROL (1.03739)-5GM - 567152-5GM, 5 g

D(+)MELEZITOSE MONOHYDRATE (1 - 444201-100GM

HISTONE DEACETYLASE SUBSTRATE - 382155-1MG

L(-)Sorbose. 250gm. Sorbose. White solid. Purity: =98% by HPLC. RTECS WG3195025, CAS 87-79-6.

Lactulose. 50gm. 4-O-beta-D-Galactopyranosyl-D-fructose. White solid. A beta-galactosidase substrate. Purity: =97% by HPLC. Heavy metals: =0.001%. RTECS LS6965000, CAS 4618-18-2.

Calcineurin Substrate. 500ug. PP2B Substrate. RII Phosphopeptide. Lyophilized solid. Hygroscopic. Peptide substrate for calcineurin. Derived from PKA regulatory subunit type II (RII). Release of phosphate can be quantified colorimetrically using malachite green method. Purity: =95% by HPLC.

Calpain Substrate II, Fluorogenic. 25mg. Suc-LY-AMC. Pale brown solid. Cyclic fluorogenic substrate for quantitative determination of calpain -1 and -2. Typical conc. range from 10-100 mM, depending on assay conditions. Purity:=95% TLC. Excitation max.-380 nm; emission max.-460 nm. CAS 94367-20-1.

CASPASE SUBSTRATE SET IV FLUO - 218809-1SET

Caspase-9 Substrate II, Colorimetric. 5mg. Ac-LEHD-pNA. Lyophilized solid. Protect from light and moisture. A colorimetric substrate for caspase-9. Cleavage is monitored colorimetrically at -405 nm. Purity:=98% by HPLC. Ac-Leu-Glu-His-Asp-pNA.

COLLAGEN TYPE I HUMAN SKIK 1MG - 234138-1MG

D (+) Glucosamine Hydrochloride. 100gm. 2-Amino-2-deoxy-D-glucose. Chitosamine. White solid. Purity: =90% by HPLC. RTECS LZ6665000, CAS 66-84-2. Ref.: Merck Index 13, 4471. MW 215.6

GANGLIOSIDE GD1B DIASIALO HU - 345742-1MG

Ganglioside GD2, Disialo, Human Brain. 500ug. GalNAc(beta)1,4(Neu5Ac(alpha)2,8)(Neu5Ac(alpha)2,03)Gal(beta)1,4Glc(beta)1,1' Ceramide. Lyophilized solid. Purity: =98% TLC. From tissue certified to be negative for HBsAg and for antibodies to HIV and HCV. CAS 65988-71-8. M.W.1675.9 .

Ganglioside GD3, Disialo, Diammonium Salt, Bovine Buttermilk. 1mg. White solid. Disrupts mitochondrial transmembrane potential and induce apoptosis in tumor cells by a caspase-independent mechanism. . Purity: =98% by TLC. M.W. 1577.0 (based on tricosanoyl - 23:0).

GANGLIOSIDE GM1 ASIALO HUMAN - 345747-1MG

Ganglioside GM4, Monosialo, Human Brain. 500ug. Neu5Ac(alpha)2,3Gal(beta)1,1' Ceramide. Lyophilized solid. Purity:=98% by TLC. Reconstitute in H2O with sonication. From tissue certified to be negative for HBsAg and for antibodies to HIV and HCV. M.W. 1019.4 (based on stearoyl - 18:0).

GANGLIOSIDE GQ1B TETRASIALO - 345754-100UG

Gluconolactone. 500gm. Glucono-(delta)-lactone. White solid. An oxidation product of glucose by glucose oxidase. Purity:=99.5% by HPLC. RTECS LZ5184000, CAS 90-80-2.

Heparin, Porcine Intestinal Mucosa, Biotin Conjugate. 10mg. Solid. Biotinylated heparin containing 5 - 8 mole-percent biotin. Biotin attachment is through a 12-atom spacer arm containing a cleavable disulfide group. M.W. 15,000 (avg.). Soluble in water.

HYALURONIC ACID BINDING PROTEI - 385910-100UG

HYALURANIC ACID BINDING PROTEI - 385911-50UG

HYALURONIC ACID BOVINE TRACHE - 385906-10MG

MMP-1 Substrate III, Fluorogenic. 1mg. Yellow solid. Protect from light. Packaged under inert gas. An excellent quenched fluorescence substrate for MMP-1. Purity:=95% HPLC. Supplied as trifluoroacetate salt. Excitation max.: -365 nm; emission max.: -450 nm. Soluble in 50% acetic acid. MW 1105.3.

MMP-1/MMP-9 Substrate, Fluorogenic. 1mg. Yellow solid. Protect from light. Quenched fluorescence substrate for MMP-1 and MMP-9. Both cleave this substrate between Gly and Cys(Me), liberating a fluorescent cleavage product. Purity:=95% HPLC. Excitation max.-365 nm; emission max.-450 nm. MW 1077.2.

Category